Biosimilars are biologic medicines that have been tested and determined to be highly similar to
a reference medicine. They have no clinically meaningful differences related to safety, purity and potency, but may have minor differences in clinically inactive components. Biosimilars are approved to
the same standard of quality, safety and efficacy as all biologic medicines.